A Randomized, Phase III, Double-Blind Study of Pemetrexe

Project: Research project

Description

A Randomized, Phase III, Double-Blind Study of Pemetrexed Plus Best Supportive Care for Advanced Non-Small Cell Lung Cancer
StatusFinished
Effective start/end date4/29/054/28/09

Funding

  • Eli Lilly and Company

Fingerprint

Pemetrexed
Double-Blind Method
Non-Small Cell Lung Carcinoma